Mitochondria‐targeted atovaquone promotes anti‐lung cancer immunity by reshaping tumor microenvironment and enhancing energy metabolism of anti‐tumor immune cells
Donghai Xiong(Medical College of Wisconsin), M. James You(Houston Methodist), Stephen T.C. Wong(Cornell University), Mofei Huang(Medical College of Wisconsin), Zheng Yin(Cornell University), Micaël Hardy(Centre National de la Recherche Scientifique), Yian Wang(Hunan Normal University), Balaraman Kalyanaraman(Medical College of Wisconsin)
Cited by 17
Related Papers
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
|Nature|2015|1.8k
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
|Cell|2006|1.4k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
Microenvironmental Regulation of Epithelial–Mesenchymal Transitions in Cancer
|Cancer Research|2012|302
A gene expression signature of TREM2hi macrophages and γδ T cells predicts immunotherapy response
|Nature Communications|2020|246